We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
New Monoclonal Antibodies to Clostridia GDH
Product News

New Monoclonal Antibodies to Clostridia GDH

New Monoclonal Antibodies to Clostridia GDH
Product News

New Monoclonal Antibodies to Clostridia GDH


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "New Monoclonal Antibodies to Clostridia GDH"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Clostridium difficile associated diarrhea (CDAD) is the leading cause of nosocomial diarrhea. The spread of this bacterium is difficult to control due to its resistant spores that survive on many surfaces.

Thus rapid detection is crucial to its control.

Most rapid tests target the toxins (A & B) produced during the infection. Another diagnostic target is glutamate dehydrogenase (GDH), an enzyme produced and released during bacterial growth.

Studies have shown that adding GDH detection together with toxin detection by EIA or PCR significantly improves assay specificity.

ViroStat has announced the release of three new monoclonal antibodies to Clostridia GDH validated by ELISA. These antibodies represent a new set of tools for rapid detection development.

Advertisement